Cargando…

Preventing Multiple Sclerosis: The Pediatric Perspective

Pediatric-onset multiple sclerosis (MS) is a predominantly relapsing-remitting neuroinflammatory disorder characterized by frequent relapses and high magnetic resonance imaging (MRI) lesion burden early in the disease course. Current treatment for pediatric MS relies on early initiation of disease-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardy, Duriel, Chitnis, Tanuja, Waubant, Emmanuelle, Banwell, Brenda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913516/ https://www.ncbi.nlm.nih.gov/pubmed/35280298 http://dx.doi.org/10.3389/fneur.2022.802380

Ejemplares similares

Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
por: Mandel, Leslie A, et al.
Publicado: (2021)

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS
por: Deiva, Kumaran, et al.
Publicado: (2020)

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study
por: Krupp, Lauren, et al.
Publicado: (2022)

Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic
por: Sandesjö, Fredrik, et al.
Publicado: (2021)

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
por: Waubant, Emmanuelle, et al.
Publicado: (2019)

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study
por: Arnold, Douglas L, et al.
Publicado: (2020)

The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis
por: Chitnis, Tanuja
Publicado: (2007)

The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
por: Tremlett, Helen, et al.
Publicado: (2021)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Editorial: Preventing multiple sclerosis
por: Dobson, Ruth, et al.
Publicado: (2022)

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006)

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

Urban air quality and associations with pediatric multiple sclerosis
por: Lavery, Amy M., et al.
Publicado: (2018)

The Potential for EBV Vaccines to Prevent Multiple Sclerosis
por: Maple, Peter A., et al.
Publicado: (2022)

Pregnancy-related healthcare utilization among women with multiple sclerosis
por: Mainguy, Marie, et al.
Publicado: (2023)

Editorial: Fatigue in multiple sclerosis—A current perspective
por: Pokryszko-Dragan, Anna, et al.
Publicado: (2023)

Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
por: Margoni, Monica, et al.
Publicado: (2021)

Gender disparities in multiple sclerosis research and leadership: A Colombian perspective
por: Casallas-Vanegas, Adriana, et al.
Publicado: (2022)

A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum
por: Barro, Christian, et al.
Publicado: (2021)

miRNA contributions to pediatric‐onset multiple sclerosis inferred from GWAS
por: Rhead, Brooke, et al.
Publicado: (2019)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis
por: Akbar, Nadine, et al.
Publicado: (2016)

Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Editorial: Women in multiple sclerosis and other demyelinating disorders: A global perspective
por: Ciampi, Ethel, et al.
Publicado: (2023)

Is multiple sclerosis a risk factor for infections?
por: Lechner-Scott, Jeannette, et al.
Publicado: (2020)

Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018)

Interval Timing in Pediatric Multiple Sclerosis: Impaired in the Subsecond Range but Unimpaired in the One-Second Range
por: Troche, Stefan J., et al.
Publicado: (2020)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
por: Greenberg, Benjamin M., et al.
Publicado: (2021)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
por: Castillo-Trivino, Tamara, et al.
Publicado: (2013)

Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients
por: Brown, Robert A., et al.
Publicado: (2014)

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
por: Vališ, Martin, et al.
Publicado: (2022)

Association of Fatigue Severity With Maladaptive Coping in Multiple Sclerosis: A Data-Driven Psychodynamic Perspective
por: Pust, Gesa E. A., et al.
Publicado: (2021)

Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes
por: Chitnis, Tanuja, et al.
Publicado: (2022)

Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study
por: Chitnis, Tanuja, et al.
Publicado: (2013)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dj2h8mibq2hnee778os4cio6kr